Lessons from companies that are defying the odds by Michael Mankins and Patrick Litre Nearly every major corporation has embarked on some sort of transformation in recent years. By our estimates, at ...

Novartis has unveiled a dazzling multi-billion dollar business deal which sees it divest its vaccines and animal health divisions, build its oncology portfolio, and create a new joint venture market ...